PUBLISHER: 360iResearch | PRODUCT CODE: 1464944
PUBLISHER: 360iResearch | PRODUCT CODE: 1464944
[180 Pages Report] The CBD Ingredients Market size was estimated at USD 6.52 billion in 2023 and expected to reach USD 7.38 billion in 2024, at a CAGR 14.05% to reach USD 16.38 billion by 2030.
The cannabidiol (CBD) ingredients market includes all products and raw materials derived from the hemp plant, specifically focusing on CBD, a non-psychoactive compound known for its potential health benefits. The market spans various sectors, including pharmaceuticals, cosmetics, food and beverages, and pet care, owing to its broad application range. The scope extends from cultivation and extraction to distributing CBD-infused products to end consumers, highlighting an intricate value chain. CBD ingredients find applications across various sectors, including pharmaceuticals, nutraceuticals, cosmetics, and food and beverages. In pharmaceuticals, CBD is used for its therapeutic properties in treating conditions such as anxiety, epilepsy, and chronic pain. In the nutraceutical sector, it is incorporated into supplements for wellness benefits. Cosmetics infused with CBD are known for their anti-inflammatory and antioxidant properties, while the food and beverage industry utilizes CBD to create wellness-oriented edible products. Several factors propel the growth of the CBD ingredients market, including the growing prevalence of chronic diseases globally, increased investment in R&D of CBD ingredients, and increasing consumer focus on wellness and natural remedies. However, the cannabidiol market is facing certain challenges, such as stringent quality and safety standards required for CBD products, consumer misconceptions, and the stigma associated with cannabis products. On the other hand, the ongoing development of novel CBD formulations and delivery methods and strategic partnerships with food, beverage, cosmetics, and pharmaceutical companies present potential growth opportunities for the CBD ingredients market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 6.52 billion |
Estimated Year [2024] | USD 7.38 billion |
Forecast Year [2030] | USD 16.38 billion |
CAGR (%) | 14.05% |
Type: Increasing preference for full spectrum CBD due to its therapeutic benefits
Broad Spectrum CBD is characterized by its comprehensive profile of naturally occurring cannabinoids, excluding THC (tetrahydrocannabinol). This type of CBD offers the entourage effect, whereby the combined effect of cannabinoids and terpenes is believed to enhance the product's overall efficacy without the psychoactive effects associated with THC. Full Spectrum CBD includes all cannabinoids found in the cannabis plant, including THC. This composition maintains the integrity of the plant's chemical profile, offering a holistic approach to CBD consumption. The presence of THC, even in minimal amounts, along with additional cannabinoids and terpenes, contributes to the entourage effect, potentially increasing the therapeutic benefits of the product. Isolate Spectrum CBD, often referred to as CBD Isolate, is nearly 100% pure CBD. During the extraction process, all other cannabinoids, terpenes, and flavonoids are removed, resulting in a product that contains solely cannabidiol. This type of CBD ingredient is free from THC and any other compounds found in the cannabis plant, making it a suitable option for consumers looking for the pure effects of CBD without the influence of other cannabinoids or the terpene profile. It's commonly found in pharmaceutical applications, certain dietary supplements, and products targeting specific wellness goals that rely on the purity and concentration of CBD.
Application: Expanding application of CBD ingredients in nutraceuticals & dietary supplements to support overall health
In the food & beverage sector, CBD is predominantly utilized for its potential health benefits without the psychoactive effects associated with THC. Products such as CBD-infused beverages, chocolates, and baked goods cater to consumers seeking relaxation, reduced anxiety, and improved sleep quality. This sector benefits from the ongoing trend towards natural and wellness-focused products. The nutraceuticals & dietary supplements segment embraces CBD for its anti-inflammatory, analgesic, and neuroprotective properties. Consumers in this segment focus on health and wellness, leveraging CBD's potential to enhance mood, aid in recovery post-exercise, and support overall health. In the personal care & cosmetics industry, CBD's anti-inflammatory and antioxidant properties are harnessed in products aimed at skin care, such as creams, serums, and balms. These items target users looking for natural ingredients to enhance skin health, alleviate conditions including acne, and provide anti-aging benefits. The pharmaceutical sector presents a significantly different application for CBD, focusing on its therapeutic potential for treating specific medical conditions. There is ongoing research into CBD's effectiveness for epilepsy, anxiety disorders, and symptom management for chronic diseases such as multiple sclerosis and cancer. In conclusion, the CBD ingredients market is diverse, with each application segment catering to specific consumer needs and preferences. While food & beverage and nutraceuticals & dietary supplements focus on general wellness and health optimization, personal care & cosmetics and Pharmaceutical segments leverage CBD's therapeutic potential to address specific health conditions and enhance skin health.
Regional Insights
The North American region, notably the United States and Canada, continues to be a major market for CBD ingredients due to increasing legalization, societal acceptance, and an expanding array of CBD-infused products. Regulatory advancements, especially in the U.S. following the 2018 Farm Bill, have supported the expansion of CBD in both consumer and pharmaceutical domains. In South America, the burgeoning interest in CBD ingredients is noteworthy, particularly in Uruguay and Colombia, which have taken progressive steps toward cannabis legalization. This region shows growth potential bolstered by agricultural capabilities and regulatory shifts. Europe's CBD market exhibits considerable diversity in regulation and countries such as Germany, the UK, and Switzerland are at the forefront, driven by favorable regulatory atmospheres and high consumer interest. However, the EU's Novel Food Regulation has been a critical regulatory milestone, providing a pathway for CBD foods and supplements. The Middle East presents a challenging market for CBD products, with stringent anti-cannabis laws across many countries. However, there is a small but growing interest in CBD for medicinal purposes. Africa's CBD market is in early development, with South Africa being the most notable market. The continent shows potential for both the cultivation of hemp and the development of CBD markets, driven by a growing awareness of CBD's health and wellness benefits. The APAC region is witnessing a slow but steady interest in CBD, primarily led by countries such as Australia and Thailand. China is appearing as a significant player in the CBD hemp cultivation and export markets despite stringent regulations around CBD consumption. Recent patents in China focus on hemp genetics and CBD extraction technologies. Japan maintains a strict zero-tolerance policy for THC, placing an emphasis on CBD purity. Recent regulatory relaxations have led to an increase in available CBD-infused products, from skincare to supplements. India's CBD market is in its nascent stages, with significant legal and cultural barriers to widespread adoption. However, the traditional use of cannabis in Ayurvedic practices and growing awareness signal a future market potential.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the CBD Ingredients Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the CBD Ingredients Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the CBD Ingredients Market, highlighting leading vendors and their innovative profiles. These include Aurora Cannabis Inc., Bedrocan, BIOTA Biosciences LLC, CannazALL, Cannoid LLC, Canopy Growth Corp., CBD American Shaman LLC, CV Sciences, Inc., Elixinol, Endoca BV, Folium Biosciences, Gaia Botanics, Global Cannabinoids, Green Roads Inc., Happie Hemp Pvt. Ltd., Isodiol International Inc,, Kazmira LLC, Maricann, Inc., Medical Marijuana Inc., Mile High Labs International Inc., NuLeaf Naturals, LLC, PharmaHemp d.o.o., Rhizo Sciences, Sequoya, and SPARKCBD.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the CBD Ingredients Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the CBD Ingredients Market?
3. What are the technology trends and regulatory frameworks in the CBD Ingredients Market?
4. What is the market share of the leading vendors in the CBD Ingredients Market?
5. Which modes and strategic moves are suitable for entering the CBD Ingredients Market?